MonTa Biosciences
Steven Glazer is the current Chief Medical Officer at Monta Biosciences. Prior to joining Monta, Steven served as the Chief Medical Officer at Hansa Medical and RhoVac. Steven has also served on the Board of Directors and as the Chair of Scientific Board for Immunicum AB. In addition to their work in the biotech industry, Steven is also a Drug Development Consultant and the owner of Glazer Consulting APS.
Steven received their medical degree from the University of Copenhagen in 2004. Steven then went on to complete their PhD in experimental medicine from the same institution in 2009. Steven’s research has focused on cancer immunotherapy and they have authored or co-authored over 50 scientific papers in the field. In addition to their work in research and development, Steven has also served as a clinical investigator on numerous Phase I-III clinical trials.
Steven Glazer attended Københavns Universitet - University of Copenhagen, where they earned their Doctor of Medicine (MD).
Steven Glazer reports to Simon Skjøde Jensen, CEO. Some of their coworkers include and Morten Just Petersen - CDO.
MonTa Biosciences
MonTa Biosciences is a clinical stage biotech company located in the science park of The Danish Technical University in Kgs. Lyngby, North of Copenhagen. Their technology is a novel cancer immunotherapy approach using micelles to stimulate immune cells to migrate into tumor tissue leading to tumor cell killing within hours.